Latest news
Nuvectis Reports $7.0 Million Q2 Net Loss After Pipeline Deals - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 12:31:00 GMTNuvectis Pharma Reports Q2 2026 Results, Highlights In-Licensing of Ciprocopan and NXP200 and $115 Million Follow-On Offering - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 12:20:00 GMT